Business Wire

CA-ARMIS

24.6.2024 17:16:26 CEST | Business Wire | Press release

Share
Armis Named ‘Outperformer’ and ‘Leader’ in GigaOm Radar Report for Operational Technology Security for Second Consecutive Year

Armis, the asset intelligence cybersecurity company, today announced that it has been named a Leader and Outperformer in the 2024 GigaOm Radar Report for Operational Technology (OT) Security. This is the second year running is recognized as a Leader in the field of OT Security, cementing its status as a mature platform solution providing proactive end-to-end security for cross-vertical organizations looking for a cohesive approach to OT Security management.

Armis scored multiple 5/5 perfect scores showcasing Armis’ customer-centric vision to deliver OT security built on deep asset context, proactive threat intelligence and total vulnerability management. From cost and ease of use to scalability and flexibility and certification, Armis was recognized for being built for smooth deployment in OT environments.

“The on-going development of the Armis Centrix™ platform has enabled us to offer complete end to end OT security management from complete visibility, vulnerability remediation and management through to advanced AI threat detection,” said Yevgeny Dibrov, CEO and Co-founder of Armis. “I am grateful to GigaOm for recognizing, not just our leadership position, but also awarding us 'Outperformer status', praising the developments we have made this past year.”

The GigaOm Radar is a thoroughly comprehensive technology analysis of OT security solutions on the market today, focusing on the latest innovation and critical capabilities that customers need to protect their entire environment. It also benchmarks current solutions and is able to effectively track how OT/ICS security has evolved in order to stay ahead of modern threat actors and attack vectors.

“Armis has excelled in rapidly advancing its technological offerings and has notably enhanced its threat detection capabilities over the past year, pushing the boundaries of innovation in OT security,” said Chris Ray, Research Analyst at GigaOm. “Armis is positioned as a Platform Play because it offers an extensive and integrated security platform capable of addressing multiple OT security concerns, making it well-suited for organizations seeking comprehensive solutions. It is classified as Innovative due to its aggressive approach in introducing new features and capabilities, which highlights its commitment to staying ahead in technology advancements. Armis has achieved Leader status thanks to its effective market penetration and the robustness of its security solutions.”

Within the GigaOm Radar for OT Security, Armis Centrix™ is recognized for:

  • Asset Discovery - Armis' automated asset discovery feature received a 5/5 score for surpassing traditional methods by incorporating passive network discovery, active asset querying techniques, integration-based approaches, and asset profiling. This thorough strategy ensures precise identification of all devices, managed or unmanaged, granting organizations a complete view of their network landscape.
  • Dynamic Network Segmentation - Additionally, Armis received a 5/5 score for its dynamic network segmentation, utilizing knowledge of VLANs, subnets, and wireless networks to create device segments as the dynamic attack surface requires, and provide insights into architectural changes for more secure environments.
  • Managing Complex, Converged Environments - Armis demonstrated proficiency in managing diverse environments, including the OT, IT, IoT, and medical sectors. Armis Centrix™ showcased strong adherence to industry standards and regulatory requirements, scoring a 5/5 for business certification criterion thus instilling trust and confidence in its customers. Notable certifications include FedRAMP, DoD Impact Level 4, ISO 27001, ISO 28018, and SOC 2 type 2.
  • Next-Generation AI Threat Detection - With the addition of actionable threat intelligence capabilities this year Armis displayed huge growth in AI technologies for threat detection. Scoring a 5/5, Armis was applauded for using AI to identify attacks still in the formulation stage as well as pinpointing anomalous behavior, unusual activities, malicious code, and other threats in real time. Armis integrates with SIEM, SOAR, XDR, and ASM solutions, ensuring comprehensive coverage and visibility across the entire attack surface.
  • Integration with IT security systems - Ensuring coordinated security efforts across both IT and OT environments. This convergence enhances the overall cybersecurity posture of an organization, addressing complex, multifaceted threats that span the IT-OT divide.
  • Providing visualization of OT asset relationships - Offering best-in-class dashboards and Purdue modeling to represent how OT assets connect and interact within an organization's network. This visibility is essential for understanding potential pathways of cyber threats and optimizing security responses.

“Armis offers a comprehensive suite of security features well-suited for SMBs, large enterprises, and public sector organizations,” continued Ray. “Leaders like Armis demonstrate robust platform capabilities with wide-reaching security features, making them stalwarts in the industry.”

The 2024 GigaOm Radar Report is a valuable resource for organizations aiming to enhance their OT security posture. It offers a thorough overview of the OT security market and highlights the leading vendors in the space. To learn more, read the Armis blog highlighting key findings from this year’s report here.

About Armis

Armis, the asset intelligence cybersecurity company, protects the entire attack surface and manages the organization’s cyber risk exposure in real time. In a rapidly evolving, perimeter-less world Armis ensures that organizations continuously see, protect and manage all critical assets – from the ground to the cloud. Armis secures Fortune 100, 200 and 500 companies as well as national governments, state and local entities to help keep critical infrastructure, economies and society stay safe and secure 24/7. Armis is a privately held company headquartered in California.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240624790874/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye